Five preference-based indexes in cataract and heart failure patients were not equally responsive to change

被引:44
作者
Kaplan, Robert M. [1 ]
Tally, Steven [2 ,3 ]
Hays, Ron D. [4 ]
Feeny, David [5 ]
Ganiats, Theodore G. [2 ,3 ]
Palta, Mari [6 ]
Fryback, Dennis G. [6 ]
机构
[1] Univ Calif Los Angeles, Dept Hlth Serv, Sch Publ Hlth, Los Angeles, CA 90095 USA
[2] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA
[3] Univ Calif San Diego, Hlth Serv Res Ctr, San Diego, CA 92103 USA
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[5] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA
[6] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA
基金
美国国家卫生研究院;
关键词
Quality of life; Measurement; Responsiveness; Cost-utility analysis; Quality-adjusted life years (QALY); Preference measure; QUALITY-OF-LIFE; HEALTH UTILITIES INDEX; WELL-BEING SCALE; VISUAL FUNCTION QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; CLINICAL-TRIALS; VALIDITY; SF-36; MULTIATTRIBUTE; RELIABILITY;
D O I
10.1016/j.jclinepi.2010.04.010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To compare the responsiveness to clinical change of five widely used preference-based health-related quality-of-life indexes in two longitudinal cohorts. Study Design and Setting: Five generic instruments were simultaneously administered to 376 adults undergoing cataract surgery and 160 adults in heart failure management programs. Patients were assessed at baseline and reevaluated after 1 and 6 months. The measures were the Short Form (SF)-6D (based on responses scored from SF-36v2), Self-Administered Quality of Well-being Scale (QWB-SA), the EuroQol-5D developed by the EuroQol Group, the Health Utilities Indexes Mark 2 (HUI2) and Mark 3 (HUI3). Cataract patients completed the National Eye Institute Visual Functioning Questionnaire-25, and heart failure patients completed the Minnesota Living with Heart Failure Questionnaire. Responsiveness was estimated by the standardized response mean. Results: For cataract patients, mean changes between baseline and 1-month follow-up for the generic indices ranged from 0.00 (SF-6D) to 0.052 (HUI3) and were statistically significant for all indexes except the SF-6D. For heart failure patients, only the SF-6D showed significant change from baseline to 1 month, whereas only the QWB-SA change was significant between 1 and 6 months. Conclusions: Preference-based methods for measuring health outcomes are not equally responsive to change. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:497 / 506
页数:10
相关论文
共 39 条
[1]  
[Anonymous], 1992, Measuring functioning and well-being: The medical outcomes study EApproach
[2]   Health Utilities Index Mark 3 showed valid in Alzheimer disease, arthritis, and cataracts [J].
Asakawa, Keiko ;
Rolfson, Darryl ;
Senthilselvan, Ambikaipakan ;
Feeny, David ;
Johnson, Jeffrey A. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (07) :733-739
[3]   Letter to the editor: Comments on health-related quality of life of adults surviving malignancies in childhood [J].
Barr, RD ;
Furlong, W ;
Feeny, D .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) :506-507
[4]   Health-related quality of life in survivors of Wilms' tumor and advanced neuroblastoma: A cross-sectional study [J].
Barr, RD ;
Chalmers, D ;
De Pauw, S ;
Furlong, W ;
Weitzman, S ;
Feeny, D .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3280-3287
[5]   Is the Health Utilities Index valid in total hip arthroplasty patients? [J].
Blanchard, C ;
Feeny, D ;
Mahon, JRL ;
Bourne, R ;
Rorabeck, C ;
Stitt, L ;
Webster-Bogaert, S .
QUALITY OF LIFE RESEARCH, 2004, 13 (02) :339-348
[6]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[7]   Multiattribute and single-attribute utility functions for the health utilities index mark 3 system [J].
Feeny, D ;
Furlong, W ;
Torrance, GW ;
Goldsmith, CH ;
Zhu, ZL ;
DePauw, S ;
Denton, M ;
Boyle, M .
MEDICAL CARE, 2002, 40 (02) :113-128
[8]   MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX [J].
FEENY, D ;
FURLONG, W ;
BOYLE, M ;
TORRANCE, GW .
PHARMACOECONOMICS, 1995, 7 (06) :490-502
[9]  
Feeny D, 1998, MED PEDIATR ONCOL, P54
[10]  
Feeny D, 1999, INT J CANCER, P2